To Evaluate the Efficacy Treatment of Lower Extremity Pathologies Derived From Neurological Ischemia Disorders
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,000
- 主要终点
- Primary Outcome: Scientific record of treatment success or failure
研究概览
简要总结
Physician Clinical Trial Policy (CTP) to evaluate the efficacy treatment of lower extremity pathologies derived from neurological ischemia disorders using the combination of Monochromatic Infrared Photo Energy (MIRE) and Transcutaneous Electrical Nerve Stimulation (TENS) therapies.
详细描述
Although there are a number of pain disorders, associated with back, or lower extremity pain and swelling, the American Association of Sensory Electrodiagnostic Medicine (AASEM/ DTSC) study programs will accumulate received data following a protocol of treatment performed for the purpose of eliminating pain, reducing swelling, and accelerating recovery periods as well as to record the success or failure and/or improvement of the malfunctioning body part.
- Condition: Neuropathic Pain, Tingling or Numbness derived from neurological Ischemia
- Intervention: Treatments of Monochromatic Infrared Photo Energy (MIRE) in combination with Electronic Signal Treatment (TENS) therapy
- Study Type: Interventional
- Study Design:
- Allocation: Non-Randomized
- Endpoint Classification: Efficacy Study
- Intervention Model: Single Group Assignment
- Masking: Open Label
- Primary Purpose: Scientific record of treatment success or failure
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •In the investigator's judgment, a high probability of 5 year survival and compliance with the study visit schedule.
- •Ability to comprehend and sign an informed consent document prior to study enrollment.
排除标准
- •Any other excluding factors that, according to the investigator's judgment, would preclude enrollment in the study.
结局指标
主要结局
Primary Outcome: Scientific record of treatment success or failure
时间窗: 5 years
次要结局
未报告次要终点